Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-07-16

Clinical Trial Update: ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of the irbesartan/hydrochlorothiazide combination for hypertension has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AVALIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)

Snippet

Sponsor: Sanofi | Conditions: Hypertension | Phase 4 | Status: COMPLETED